| Followers | 1072 |
| Posts | 89933 |
| Boards Moderated | 3 |
| Alias Born | 07/26/2007 |
Sunday, January 19, 2014 3:38:46 PM
CURXQ is currently extremely undervalued ($8K for the entire float) and extremely oversold (from 0.007 to 0.0004)! Only 16,238,300 shares fixed tiny float! The recent high was 0.007 v.s. at the joke low 0.0005 now! Easy 14-bagger from here with the same fixed small SS...
The pharmaceutical company had been developing Memryte, an Alzheimer’s drug that had stalled during Phase 3 clinical trials and was slated for renewed Phase 2b trials. Curaxis currently has one U.S. patent for Alzheimer’s treatment (which could worth up to multiple hundreds millions of dollars or more) and has two additional patents pending.
The pharmaceutical company had been developing Memryte, an Alzheimer’s drug that had stalled during Phase 3 clinical trials and was slated for renewed Phase 2b trials. Curaxis currently has one U.S. patent for Alzheimer’s treatment (which could worth up to multiple hundreds millions of dollars or more) and has two additional patents pending.
OTC-Killers-Club has spot 223 stock killers from 4900-bagger to 2.33-bagger since 03/05/2011
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
